Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Methods. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of 20 seropositive individuals was followed-up to analyze IgG persistence. For the IgG anti-SARS-CoV-2 antibodies detection, the COVID-AR IgG® ELISA kit was used. Results. 3 000 individuals were included conforming asymptomatic and pauci-symptomatic groups (n=1 500 each). From the total sample, only 8.83% (n=265) presented reactivity for IgG anti-SARS-CoV-2. A significant association was observed between positive anti-SARS-CoV-2 IgG and a history of contact with a confirmed case; the transmission rate within households was approximately 30%. In the pauci-symptomatic group, among the seropositive ones, anosmia and fever presented an OR of 16.8 (95% CI 9.5-29.8) and 2.7 (95% CI 1.6-4.6), respectively (p <0.001). In asymptomatic patients, IgG levels were lower compared to pauci-symptomatic patients, tending to decline after 4 months since the symptoms onset. Conclusion. We observed a low seroprevalence, suggestive of a large population susceptible to the infection. Anosmia and fever were independent significant predictors for seropositivity. Asymptomatic patients showed lower levels of antibodies during the 5-month follow-up. IgG antibodies tended to decrease over the end of this period regardless of symptoms..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Revista Panamericana de Salud Pública - 45(2021), 66, Seite 8 |
| Sprache: |
Englisch ; Spanisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Luz María Rodeles [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Anosmia |
|---|
| doi: |
10.26633/RPSP.2021.66 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ059159154 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ059159154 | ||
| 003 | DE-627 | ||
| 005 | 20230308232018.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.26633/RPSP.2021.66 |2 doi | |
| 035 | |a (DE-627)DOAJ059159154 | ||
| 035 | |a (DE-599)DOAJb27fe7e22cee401590236415bf3c561f | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a spa |a por | ||
| 050 | 0 | |a RC955-962 | |
| 050 | 0 | |a RA1-1270 | |
| 100 | 0 | |a Luz María Rodeles |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective. To evaluate the seroprevalence of COVID-19 infection in pauci-symptomatic and asymptomatic people, the associated epidemiological factors, and IgG antibody kinetic over a 5-month period to get a better knowledge of the disease transmissibility and the rate of susceptible persons that might be infected. Methods. Seroprevalence was evaluated by a cross-sectional study based on the general population of Santa Fe, Argentina (non-probabilistic sample) carried out between July and November 2020. A subgroup of 20 seropositive individuals was followed-up to analyze IgG persistence. For the IgG anti-SARS-CoV-2 antibodies detection, the COVID-AR IgG® ELISA kit was used. Results. 3 000 individuals were included conforming asymptomatic and pauci-symptomatic groups (n=1 500 each). From the total sample, only 8.83% (n=265) presented reactivity for IgG anti-SARS-CoV-2. A significant association was observed between positive anti-SARS-CoV-2 IgG and a history of contact with a confirmed case; the transmission rate within households was approximately 30%. In the pauci-symptomatic group, among the seropositive ones, anosmia and fever presented an OR of 16.8 (95% CI 9.5-29.8) and 2.7 (95% CI 1.6-4.6), respectively (p <0.001). In asymptomatic patients, IgG levels were lower compared to pauci-symptomatic patients, tending to decline after 4 months since the symptoms onset. Conclusion. We observed a low seroprevalence, suggestive of a large population susceptible to the infection. Anosmia and fever were independent significant predictors for seropositivity. Asymptomatic patients showed lower levels of antibodies during the 5-month follow-up. IgG antibodies tended to decrease over the end of this period regardless of symptoms. | ||
| 650 | 4 | |a seroprevalence | |
| 650 | 4 | |a sars-cov-2 | |
| 650 | 4 | |a asymptomatic diseases | |
| 650 | 4 | |a anosmia | |
| 650 | 4 | |a epidemiology | |
| 650 | 4 | |a argentina | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Arctic medicine. Tropical medicine | |
| 653 | 0 | |a Public aspects of medicine | |
| 700 | 0 | |a Luz María Peverengo |e verfasserin |4 aut | |
| 700 | 0 | |a Romina Benítez |e verfasserin |4 aut | |
| 700 | 0 | |a Nadia Benzaquen |e verfasserin |4 aut | |
| 700 | 0 | |a Priscila Serravalle |e verfasserin |4 aut | |
| 700 | 0 | |a Ana Karina Long |e verfasserin |4 aut | |
| 700 | 0 | |a Virginia Ferreira |e verfasserin |4 aut | |
| 700 | 0 | |a Agostina Daiana Benitez |e verfasserin |4 aut | |
| 700 | 0 | |a Luisina Zunino |e verfasserin |4 aut | |
| 700 | 0 | |a Camila Lizarraga |e verfasserin |4 aut | |
| 700 | 0 | |a Miguel Hernán Vicco |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Revista Panamericana de Salud Pública |d Pan American Health Organization, 2018 |g 45(2021), 66, Seite 8 |w (DE-627)DOAJ000129496 |x 16805348 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2021 |g number:66 |g pages:8 |
| 856 | 4 | 0 | |u https://doi.org/10.26633/RPSP.2021.66 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/b27fe7e22cee401590236415bf3c561f |z kostenfrei |
| 856 | 4 | 0 | |u https://iris.paho.org/handle/10665.2/54288 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1020-4989 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1680-5348 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2021 |e 66 |h 8 | ||